ER 230
Latest Information Update: 12 Nov 1999
At a glance
- Originator Ergo Science
- Class Anorectics
- Mechanism of Action Dopamine receptor agonists; Dopamine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 12 Nov 1999 Discontinued-Preclinical for Obesity in USA (Unknown route)
- 14 Sep 1998 No-Development-Reported for Obesity in USA (Unknown route)
- 16 Jan 1996 New profile